BLADDER TUMOURS A REVIEW OF 150 PATIENTS TREATED AT THE INSTITUTE OF UROLOGY AND NEPHROLOGY GENERAL HOSPITAL KUALA LUMPUR

Similar documents
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Experience with malignant tumours of the maxillary sinus in the Department of Otolaryngology Universiti Kebangsaan Malaysia, Kuala Lumpur

Staging and Grading Last Updated Friday, 14 November 2008

BLADDER CANCER: PATIENT INFORMATION

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Types of bladder cancer

Bladder cancer - suspected

250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

A patient with recurrent bladder cancer presents with the following history:

Bladder Cancer Guidelines

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Glossary of Terms Primary Urethral Cancer

Renal tumors of adults

Organ-sparing treatment of invasive transitional cell bladder carcinoma

Guidelines for the Management of Bladder Cancer

Haematuria and Bladder Cancer

Radical Cystectomy Often Too Late? Yes, But...

EAU GUIDELINES ON NON-MUSCLE INVASIVE (TaT1, CIS) BLADDER CANCER

Carcinoma of the Urinary Bladder Histopathology

Urology An introduction to cut up DR J R GOEPEL

MEDitorial March Bladder Cancer

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Urogenital Malignancies Oct 15-17,2010 Constantine Algeria. President of Jordan Oncology Society Secretary General of AMAAC


Urinary Bladder, Ureter, and Renal Pelvis

Lung cancer in Malaysia

Transitional Cell Carcinoma of the Upper Ureter Metastatic to the Thoracic Spine Presenting as a Spinal Cord Compression

Care of bladder cancer patients diagnosed in Northern Ireland 2010 & 2011 (Summary)

Pure non-bilharzial squamous cell carcinoma: An unusual form of carcinoma of the bladder

Urological Tumours 1 Kidney tumours 2 Bladder tumours

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder


NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Diagnosis and classification

6 UROLOGICAL CANCERS. 6.1 Key Points

The pathology of bladder cancer

Bone Metastases in Muscle-Invasive Bladder Cancer

Quiz. b. 4 High grade c. 9 Unknown

Issues in the Management of High Risk Superficial Bladder Cancer

BLADDER CANCER CONTENT CREATED BY. Learn more at

NMIBC. Piotr Jarzemski. Department of Urology Jan Biziel University Hospital Bydgoszcz, Poland

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

UROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT

Costing report: Bladder cancer

The innovative aspect is that it detects bladder cancer based on the novel biomarker, minichromosome maintenance complex component 5 (MCM5).

Citation International journal of urology (2. Right which has been published in final f

Review of Clinical Manifestations of Biochemicallyadvanced Prostate Cancer Cases

Subject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49

Update on Haematuria and Bladder Cancer

Hey Doc, there s blood in my urine Evaluation of hematuria. Christian S. Kuhr, MD FACS May 4, 2018

THE CLASSIFICATION OF BLADDER TUMOURS

Cystitis cystica mimicking as bladder tumour

Reviewing Immunotherapy for Bladder Carcinoma In Situ

Primary Squamous Cell Carcinoma Of Kidney - A Case Report And Review Of Literature.

Veterans and Bladder Cancer webinar. Part I: Medical Overview

Afterword: The Paris System for Reporting Urinary Cytology

Carcinoma of the Renal Pelvis and Ureter Histopathology

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto

Etiology and diagnosis of bladder cancer

Pathology Driving Decisions

CYSVIEW. CONFIDENCE AT FIRST SIGHT

A215- Urinary bladder cancer tissues

Information for Patients. Bladder Cancer. English

Bladder cancer: National Collaborating Centre for Cancer. diagnosis and management. Clinical Guideline. 28 July 2014.

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Management of High Grade, T1 Bladder Cancer Douglas S. Scherr, M.D.

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Technique of transurethral needle core biopsy to confirm invasive bladder cancer staging

Clinical patterns and treatment complications of 1000 cases of carcinoma of the uterine cervix

Vaginal intraepithelial neoplasia

Pathology of bladder cancer in Egypt; a current study.

Cervical cancer presentation

비뇨병리연구회공청회 조남훈 연세대학교병리학교실

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Collection of Recorded Radiotherapy Seminars

Clinical Trials: Non-Muscle Invasive Bladder Cancer. Tuesday, May 17th, Part II

Information for Patients. Primary urethral cancer. English

Symptoms, Diagnosis and Classification

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 24/June 16, 2014 Page 6628

9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups

International Journal of Health Sciences and Research ISSN:

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

Cystitis cystica is a rare chronic reactive inflammatory

Histological Typing Of Cancer And Precancer Of The Oral Mucosa

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer ANewAnalysis

Rare Small Cell Carcinoma in Genitourinary Tract: Experience from E-Da Hospital

Advanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate

Bladder Cancer Diagnostic Tests

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Transcription:

Med. J. Malaysia Vol. 38. No. I March 1983. BLADDER TUMOURS A REVIEW OF 150 PATIENTS TREATED AT THE INSTITUTE OF UROLOGY AND NEPHROLOGY GENERAL HOSPITAL KUALA LUMPUR ZAKRIYA MAHAMOOTH HUSSAIN AWANG SUMMARY One hundred and fifty patients with urothelial tumours were reviewed. They form the majority of patients with bladder cancer referred to the Institute ofurology over the past three years. From the study it becomes very apparent that the majority ofpatients are seen late in the course of their disease. The results of treatment of patients with early lesions have been satisfactory but the patients with late invasive lesions have very poor prognosis. A plea is made that one be more aware of this condition and that symptoms ofhaematuria and urinary tract infections should have a full urological assessment early. INTRODUCTION The management of urothelial tumours forms a substantial part of the work of a Urology Zakriya Mahamooth, M.B.B.S., F.R.C.S. (Ed), Department of Sugery, Faculty of Medicine, Universiti Kebangsaan Malaysia, jalan Raja Muda, Kuala Lumpur. Hussain Awang, M.B.B.S., F.R.A.C.S. Department of Urology, Institute of Urology and Nephrology, General Hospital, Kuala Lumpur, Malaysia. Correspondence to: Zakriya Mahamooth, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Raja Muda, Kuala Lumpur. Department. It had been estimated that in the United States of America alone 9400 patients would die of bladder cancer in 1980 and 28,700 new cases will be diagnosed each subsequent year. 1 From our experience at the Institute of Urology bladder tumours comprise the majority of urinary tract tumour~ and the average incidence being about three new cases per month over the last few years. MATERIALS AND METHODS This study includes 150 patients with histologically proven neoplastic change of the urothelium. None of the patients had primary neoplasms elsewhere. The study was made with particular reference to age, sex, and ethnic group, and details of individual symptoms. RESULTS AND DISCUSSION One hundred and fifty patients were referred to the Institute. Majority of these patients were those seen over the period 1978 to 1981. Eighty-six percent of patients were resident in the more populous states of West Malaysia. This is shown in Fig. 1. Age The patients ages ranged from 25 to 87 years. This is shown in the block graph of Fig. 2. There is a high incidence in the 70-79 years age group. Ethnic Groups The majority of the patients (60 percent) were of Chinese descent, 27.4 percent were of Malay descent (Table I). Symptoms Haematuria was the most common single symptom present in 80 percent of patients. The 4

3, I \ \ \.\ \,_,,,.,_I"" 3 "----" \, \" \ \,..."'\. t \, 10 '...,... ----"... I,,,-~... ~--...,2~'" J "... \... { ''>--,. I 9..., /,--...',~...< TABLE I ETHNIC AND SEX INCIDENCE OF UROTHELIAL TUMOURS IN 150 PATIENTS Ethnic Group Male Female Total Percentage Malay 36 5 41 27.8 Chinese 75 17 92 60.9 Indian 14 2 16 10.5 Others I 1 00.6 TABLE 11 SIGNS AND SYMPTOMS OF PRESENTATION AT THE INSTITUTE S-S % Period Of Of Patient Complaint Mean Haematuria 80 20d - 7 yrs 8rn Lower Urinary Tract Infection 18.6 2m-3yrs 5rn Features of Malignancy 5.3 lrn Chronic Renal Failure 0.6 lrn Acute Retention 2 Suprapubic Mass 1.3 3rn Fig. 1 Geographic distribution of patients referrals. 50 Distant Node f!!!i!j O 2 40 Local Node r;:jjffj 0, 20 ":': ~M OF 10 Fig.2,20-29 30-39 AGE IN YRS, Age distribution of Urothelia1 tumours. time of onset of the symptom to diagnosis varied considerably. This is shown in Table 11. Lower urinary tract infection was the next common symptom. 0.6 percent of patients had uraemia secondary to a large mass producing obstruction at the ureterovesical junction or at the bladder neck. Weight loss and suprapubic discomfort were the other presentations. Stage at Initial Diagnosis Endoscopic and palpable findings together with the depth of invasion were used as guidelines to assess the clinical stage in each case according to the Fig. 3 2 Stage and grade of tumors. Depicts relationship between depth of infiltration and grade of malignancy described by Marshall's modification of Jewett's original classification of relationship of grade to stage. (Marshall VF: J Urol 68:714-723, 1972 The Williams & Wilkins Co., Baltimore) Fig. 24-1. Marshall's modification of Jewette and Strong classification. 2 This is represented in Fig. 3. The percentage of patients in each stage as assessed at the initial cystoscopy is depicted in Fig. 4. The majority of our patients were noted to be in stage C of the disease. Findings at Cystoscopy Single lesions were found only in 88 patients. Most common location of single tumours was on the 5

,...:.S::.:UP.=E:..::RF..:I::.:CI:.;,;A=.L ---:I;;,;N=VAS.;:.IVE:.:... W lik FIGURESI 80', I 20'. OUR STUDY _1_1_,3...J%Il-- 88% 70 46% 60 LATERAL WALL 50 40 30 10.2 URETIlRA O. 8% 20 10 11.3'. 17 AMERICAN FIGURES A 8 1 R 2 Fig. 4 Graphic representation of stage at first presentation to the Institute of Urology. lateral walls of the bladder. This is shown in Fig. 5. Multiple lesions were documented in 30 patients. In 74.2 percent of patients the tumour was noted to be greater than 5cms at its base or involved almost the entire bladder surface as seen at cystoscopy. The most common morphological appearance was a papillary pedunculated tumour, Histology Majority of patients had transitional cell carcinoma, Squamous metaplasia was noted in a patient and adenocarcinoma was noted in 2. Unfortunately there was no indication as to the histological grading in most pathological reports received. TREATMENT AND RESULTS Patients with stage A tumours (superficial) were subjected to transurethral resection. They were subsequently followed up with cystoscopies every 3 months. The period between cystoscopies Fig. 5 Sites of tumours seen. was increased when it was evident that the mucosa was stable. Follow up is life long. Early invasive tumours designated as B. were resected and managed as above. When the tumour was noted to invade the muscle deeply (Stage B2) the patient would be subjected to low dose ( ~ 4000 RADS) Deep x-ray therapy and a total cystectomy with urinary diversion would be performed for consenting patients. Alternatively those refusing surgery would be advised transurethral resection followed by deep x-ray therapy. Tumours in stage C 9% 6

TABLE III TREATMENT OF LOCALLY INVASIVE TUMOURS (STAGE B2, C) No. Treatment Response Percentage Follow Up Comment 45 TUR & DXT 16 32 12m 30 TUR Defaulted after initial DXT Side Effects 4 Partial Cystectomy and TUR 4 100 24m-30m Tumour free 5 Preoperative DXT FoIl total 4 100 3m-7m 1 Awaiting Cystectomy operation or D were referred for palliative deep x-ray therapy. Intravesical chemotherapy (Adriamycin 50 mg monthly for four months) would be considered should there be multiple superficial tumours or multiple superficial recurrences in the hope of controlling the disease. The above modalities outline the present policy of the institute in the management of bladder tumours....,""...,...,...,... Tumours Sixty-six patients when assessed initially were considered to have superficial tumours. They were treated by transurethral resection and coagulation of the tumour base. It was possible to recognise a response in 55 patients or 84.6 percent of patients so treated. Five of the patients were noted to develop multiple recurrences. They were put on intravesical chemotherapy with adriamycin. Initially the mucosa seemed responsive in four patients but with continued follow up it is becoming apparent that the stability of bladder mucosa is not permanent. One young patient aged 24 years however has had a visible response to the chemotherapeutic agent Epodyl he received while in London. He is tumour free after a period of four years. Four patients were referred for radiotherapy when it was found that the tumour had recurred extensively. These 4 patients have shown to exhibit stable urothelium over a period of follow up varying from 20 months to 36 months. One other patient developed paraplegia but showed a stable urothelium on cystoscopy. Three patients died of unrelated causes. Invasive Tumours In Table fifty patients received radiotherapy following partial resection of the tumour. In only 16 patients (32 percent) were we able to document a response over a mean follow up period of 12 months. Of the 34 (68 percent) in whom the tumour was not irradicated, 10 showed significant downstaging of tumour enough for us to suggest salvage cystectomy. They refused operation. Of the 34, five patients had invasive but surgically resectable tumours. Four of them were referred for low dose radiotherapy ( ~ 4000 RADS) and followed by immediate total cystectomy and urinary diversion. One is awaiting operation. Though the follow up of these patients has been short (7 months) the patients are well and have adjusted well to their ileostomy. Four patients developed extensive metastases and were discharged while 15 of the patients have been lost to follow up. Four separate patients have been on our follow up after partial cystectomy for resectable deep lesions. They are tumour free on follow up periods ranging from 24 months to 30 months. DISCUSSION Urothelial tumours can be considered as a chronic neoplastic diathesis. There is a high recurrence rate observed in patients with superficial or low stage bladder cancer. It is interesting to note that 80 percent of our patients had involvement of muscle or perivesical tissue on first presentation. This is in sharp contrast to figures elsewhere in Europe where two thirds of the patients have superficial papillary tumour when first seen. It is obvious many of our patients have had the disease for quite a while and that they were detected late. Even though the follow up period for our series is short and no conclusion as to the success; of our management could be drawn, this series forms the first documented group of patients with bladder cancer in this country. All persons involved in the management of bladder neoplasms need to be alert for cases where the disease is occupational. We have not been able to relate the development of urothelial cancer in this series to any industrial occupation in particular. In the United Kingdom primary neoplasms of the urothelium have been recognised as a prescribed industrial disease. 3 Carcinogens have been identified in many 7

industries and most cases of occupational bladder cancer have occurred following work in the manufacturing of dye stuffs, and in the rubber and electric cable industry. Contact to carcinogens can be as brief as a few weeks. Persons working in laboratories and in textile manufacture also run similar risk. All these persons would need a life-long follow up to detect development of urothelial change. Perhaps it would be prudent at this stage of development of Malaysian industries that the clinicians work in conjuction with the Industrial Disease Physician to identify the possible industries concerned and determine the population at risk, as it is envisaged that there would be a dramatic increase of incidence of bladder tumours in the next decade or two. Edoscopic cystodiathermy or resection remains the initial treatment for superficial tumours. Much has been written about the benefits of intravesical chemotherapy in conjunction with the above especially in frequently recurring superficial tumours. Our experience with adriamycin however has not been too encouraging but this is a small series. Radiotherapy has been the last resort for extensive invasive disease though it is difficult to comment as to its efficacy. Perhaps with accurate histological grading of tumours in the future we would be able to predict the course of the disease with more confidence and resort to radical surgery early in the course of the disease. It has however been our experience that only a few patients agree to total cystectomy and urinary diversion and hence at least for the time being early detection of bladder tumours should be our goal. It is very discouraging to note that as much as 45 patients have been lost to follow up. Thirty of these patients could not apparently stand the effects of radiotherapy and refused further treatment. It should be understood that the majority of our patients are from outstation towns and of low income group. To overcome much of these problems we have instituted a tumour registry at the Institute where all the particulars of the patients are kept. By reviewing this registry frequently it is possible to call back those patients who have defaulted follow up. It is hoped that by this means of communication we could obtain better results in the future. In conclusion it is emphasized that haematuria and cystitis like symptoms need early cystoscopy. As far as early detection of bladder tumours is concerned check cystoscopy and biopsy remain the most reliable investigation at the present time. ACKNOWLEDGEMENTS We wish to thank the Pengarah Hospital Besar Kuala Lumpur for permission to publish the figures. We are also grateful to Dr. Proehoeman, Mr. Roslan Arshad and Mr. Khairullah and to the staff of the Department of Urology who form of a team in the total management of the patients at the Institute. REFERENCES 1 M] Droller, Transitional Cell Carcinoma an Over-view in The Urologic Clinics of N. America, W B Saunders. Oct. 1980; 519-21. 2 Marshall V F Bladder Tumours.] Urology 1972,68, 714-723 3 Sheena M S, DaviewJ M, Hendry W F, Bladder Cancer as a Prescribed Industrial Disease, Guide for Clinicans, B.MJ. 1980 Feb.: 540-42. 8